To correlate XAF1 expression to clinico-pathological tumour characteristics and prognosis, patients were dichotomized into subgroups with high and low XAF1 expression using the median IRS in ccRCC as a cut-off. This evidence concerns the gene IARS1 and nonpapillary renal cell carcinoma.